4 months ago
NBIX
AnalystsPaul MatteisPaul Matteis's Stock Forecasts
AnalystsPaul Matteis
Analyst Ranking
Bottom 9%
#4778 out of 5192 analysts
Average Return
-2.27%
Win Rate
41%36 out of 88
Risk vs Reward
Poor
Good
Paul Matteis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +213.47% | $4.53 | $14.20 | 2024-11-12 - 2025-11-12 | Strong Buy |
Sionna Therapeutics IncSION | +154.32% | $14.80 | $37.64 | 2025-03-03 - 2026-02-12 | Strong Buy |
Rhythm Pharmaceuticals IncRYTM | +81.35% | $52.97 | $96.06 | 2025-03-04 - 2026-02-12 | Strong Buy |
Gw Pharmaceuticals PLCGWPH | +64.79% | $98.51 | $162.33 | 2017-10-01 - 2018-10-02 | Buy |
Dyne Therapeutics IncDYN | +62.44% | $9.85 | $16.00 | 2025-07-30 - 2026-02-12 | Strong Buy |
Paul Matteis Analyst Color
Get additional color on Paul Matteis's coverage of popular stocks
4 months ago
BMRN
Paul Matteis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Uniqure NvQURE | 3 | Strong Buy | $40.00 | +78.81% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $188.00 | +52.72% | Maintains | 2 months ago |
Lb Pharmaceuticals IncLBRX | 2 | Strong Buy | $35.00 | +43.74% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 5 | Strong Buy | $39.00 | +143.75% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 10 | Strong Buy | $508.00 | +64.68% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 6 | Hold | $25.00 | +15.69% | Maintains | 2 months ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $28.00 | +62.60% | Initiates Coverage On | 3 months ago |
Neumora Therapeutics IncNMRA | 3 | Hold | $3.00 | -7.69% | Maintains | 3 months ago |
Biomarin Pharmaceutical IncBMRN | 11 | Hold | $61.00 | +1.77% | Downgrades | 3 months ago |
Biogen IncBIIB | 7 | Strong Buy | $202.00 | +3.32% | Upgrades | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 15 | Hold | $445.00 | -4.31% | Maintains | 3 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Hold | $67.00 | -18.07% | Maintains | 4 months ago |
Pepgen IncPEPG | 3 | Strong Buy | $12.00 | +76.73% | Maintains | 5 months ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $94.00 | -2.14% | Maintains | 9 months ago |
Vigil Neuroscience IncVIGL | 2 | Hold | $8.00 | -0.62% | Downgrades | 9 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $32.00 | -14.98% | Initiates Coverage On | a year ago |
Gh Research PLCGHRS | 2 | Strong Buy | $32.00 | +113.19% | Maintains | a year ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $11.00 | +88.03% | Initiates Coverage On | a year ago |
Sage Therapeutics IncSAGE | 5 | Hold | $6.00 | N/A | Maintains | a year ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $37.00 | N/A | Upgrades | a year ago |
Alector IncALEC | 5 | Hold | $4.00 | N/A | Downgrades | a year ago |
Alto Neuroscience IncANRO | 3 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Neurogene IncNGNE | 2 | Strong Buy | $60.00 | N/A | Maintains | a year ago |
Alkermes PLCALKS | 5 | Strong Buy | $36.00 | N/A | Upgrades | a year ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 2 years ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Vistagen Therapeutics IncVTGN | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $295.00 | N/A | Maintains | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Strong Buy | $54.00 | N/A | Maintains | 4 years ago |
Leonabio IncLONA | 2 | Hold | $50.00 | N/A | Downgrades | 4 years ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $32.00 | N/A | Maintains | 4 years ago |
Climb Bio IncCLYM | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 5 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 4 | Hold | $140.00 | N/A | Downgrades | 6 years ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 3 | Buy | $60.00 | N/A | Initiates Coverage On | 7 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $2,280.00 | N/A | Maintains | 7 years ago |
Akcea Therapeutics IncAKCA | 2 | Hold | $31.00 | N/A | Maintains | 7 years ago |
Obseva SaOBSVF | 1 | Buy | $18.00 | N/A | Maintains | 8 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $64.00 | N/A | Maintains | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $340.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.